Pioglitazone and Adalat drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pioglitazone (pioglitazone hydrochloride) and Adalat (nifedipine). Common drug interactions include palpitations among females and pyrexia among males.
The phase IV clinical study analyzes what interactions people have when they take Pioglitazone and Adalat. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.
What is Pioglitazone?
Pioglitazone has active ingredients of pioglitazone hydrochloride. It is often used in diabetes. eHealthMe is studying from 12,864 Pioglitazone users. Check the latest studies of Pioglitazone.
What is Adalat?
Adalat has active ingredients of nifedipine. It is often used in high blood pressure. eHealthMe is studying from 20,940 Adalat users. Check the latest studies of Adalat.
31 people who take Pioglitazone and Adalat together, and have interactions are studied.

What are the common drug interactions of Pioglitazone and Adalat, by gender? *:
female:
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Cholangitis (infection of the bile duct)
- Septic shock (shock due to blood infection)
- Abdominal pain upper
- Anaemia (lack of blood)
- International normalised ratio increased
- Melaena (the passage of black, tarry stools)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Angina pectoris (chest pain due to ischemia of the heart muscle)
male:
- Pyrexia (fever)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Hepatic lesion
- Hyperkalaemia (damage to or disease of the kidney)
- Inappropriate antidiuretic hormone secretion
- Neoplasm malignant (cancer tumour)
- Respiratory depression (respiration has a rate below 12 breaths)
- Shock haemorrhagic (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin due to excess bleeding)
- Splenomegaly (enlargement of spleen)
- Bladder cancer
What are the common drug interactions of Pioglitazone and Adalat, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Drug ineffective
- Vascular pseudoaneurysm ruptured (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity)
60+:
- Pyrexia (fever)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Anaemia (lack of blood)
- International normalised ratio increased
- Melaena (the passage of black, tarry stools)
- Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
- Syncope (loss of consciousness with an inability to maintain postural tone)
- Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
- Bladder neoplasm (bladder tumour)
- Dehydration (dryness resulting from the removal of water)
What are the existing conditions these people have? *
- Post Herpetic Neuralgia (neuralgia caused by the varicella zoster virus): 6 people, 19.35%
- White Blood Cell Count Decreased: 5 people, 16.13%
- Type 2 Diabetes: 5 people, 16.13%
- Thrombocytopenia (decrease of platelets in blood): 5 people, 16.13%
- Neuropathy Peripheral (surface nerve damage): 5 people, 16.13%
- Nausea And Vomiting: 5 people, 16.13%
- Leukopenia (less number of white blood cells in blood): 5 people, 16.13%
- Infection: 5 people, 16.13%
- Hypersensitivity: 5 people, 16.13%
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 5 people, 16.13%
* Approximation only. Some reports may have incomplete information.
Do you take Pioglitazone and Adalat?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pioglitazone (12,864 reports)
- Adalat (20,940 reports)
Browse all drug interactions of Pioglitazone and Adalat:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pioglitazone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Adalat:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pioglitazone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Adalat and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on pioglitazone hydrochloride and nifedipine (the active ingredients of Pioglitazone and Adalat, respectively), and Pioglitazone and Adalat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Embolex and Ramipril drug interactions for men aged 60+ - 8 seconds ago
- Inspra and Cerebral Haemorrhage for Men aged 60+ - 11 seconds ago
- Drug interactions of Eplerenone and Vitamin E - 14 seconds ago
- Colazal vs. Prednisone Intensol, side effect and effectiveness comparison - 14 seconds ago
- Drug interactions of Pulmozyme and Symbicort - 20 seconds ago
- Stress And Anxiety in Ondansertron Hydrochloride, how severe and when it was recovered? - 32 seconds ago
- Could Mycophenolic Acid cause Myelodysplastic Syndrome? - 33 seconds ago
- Hypokinesia and drugs of ingredients of metamizole - 38 seconds ago
- Urosepsis and drugs of ingredients of nystatin - 38 seconds ago
- Could Amlodipine cause Po2 Increased? - 42 seconds ago